Cryo-EM Structures of Amyloid-β Fibrils from Alzheimer’s Disease Mouse Models
Authors:
- Mara ZielinskiMZMara Zielinski
- Fernanda S. Peralta ReyesFRFernanda S. Peralta Reyes
- Lothar GremerLGLothar Gremer
- Sarah SchemmertSSSarah Schemmert
- Benedikt FriegBFBenedikt Frieg
- Lili DonnerLDLili Donner
- Margitta ElversMEMargitta Elvers
- Lars N. G. NilssonLNLars N. G. Nilsson
- Stina SyvänenSSStina Syvänen
- Dag SehlinDSDag Sehlin
- Martin IngelssonMIMartin Ingelsson
Preprint
Abstract
The development of novel drugs for Alzheimer’s disease has proven difficult, with a high failure rate in clinical trials. Typically, transgenic mice displaying amyloid-β peptide brain pathology are used to develop therapeutic options and to test their efficacy in preclinical studies. However, the properties of Aβ in such mice have not been systematically compared to Aβ from the patient brains. Here, we determined the structures of nine ex vivo Aβ fibrils from six different mouse models by cryo-EM. We found novel Aβ fibril structures in the APP/PS1, ARTE10, and tg-SwDI models, whereas the human familial type II fibril fold was found in the ARTE10, tg-APP Swe , and APP23 models. The tg-APP ArcSwe mice showed an Aβ fibril whose structure resembles the human sporadic type I fibril. These structural elucidations are key to the selection of adequate mouse models for the development of novel plaque-targeting therapeutics and PET imaging tracers. One Sentence Summary: Cryo-EM structures of Aβ fibrils extracted from brains of mouse models used for Alzheimer’s disease preclinical research are presented.Keywords
All Related Versions
- Published version: Nature Neuroscience, 26 (12), 2073.
This publication has 76 references indexed in Scilit:
- Role of genes linked to sporadic Alzheimer’s disease risk in the production of β-amyloid peptidesProceedings of the National Academy of Sciences, 2012
- Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriersNeurology, 2012
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the LiteratureJournal of Neuropathology & Experimental Neurology, 2012
- Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's DiseasePLOS ONE, 2009
- Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrilsProceedings of the National Academy of Sciences, 2008
- Sensitive ELISA detection of amyloid‐β protofibrils in biological samplesJournal of Neurochemistry, 2007
- Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid β-protein precursor transgenic miceNeuroscience, 2007
- The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic miceNeurobiology of Aging, 2006
- Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid β-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid β-Protein PrecursorJournal of Biological Chemistry, 2004
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992